Airdoc Technology (02251.HK) achieved remarkable success in 2023, accelerating its commercialization in an unparalleled way
In 2023, Airdoc Technology significantly accelerated its commercialization,while most of its peers were still in the experimental stage or early stages of commercialization.
- In 2023, Airdoc Technology significantly accelerated its commercialization,while most of its peers were still in the experimental stage or early stages of commercialization.
- 2) health risk assessment solutions, covering 55 types of lesions, providing chronic disease management and health assessments for healthcare industry.
- Airdoc Technology practices the use of AI technology to assist in the prevention and control of myopia among teenagers and the development of eye health.
- In July 2023, Airdoc Technology participated in the formulation of the "Expert Consensus on Assessing the Risk of Cardiovascular Diseases Using Artificial Intelligence Technology Based on Fundus Images."